1. Cystatin C Concentration as a Predictor of Systolic and Diastolic Heart Failure 
Andrew Moran, MD, MPH, Ronit Katz, PhD, Nicolas L. Smith, PhD, Linda F. Fried, MD, MPH, Mark J. Sarnak, MD, MS, Stephen L. Seliger, MD, MS, Bruce Psaty, MD, PhD, David S. Siscovick, MD, MPH, John S. Gottdiener, MD, Michael G. Shlipak, MD, MPH 
Journal of Cardiac Failure 
Volume 14, Issue 1, Pages (February 2008)
DOI: /j.cardfail
Copyright © 2008 Elsevier Inc. Terms and Conditions

2. Fig 1 Selection of participants included from the CHS.
Journal of Cardiac Failure  , 19-26DOI: ( /j.cardfail )
Copyright © 2008 Elsevier Inc. Terms and Conditions

3. Fig 2
Incidence rates for HF categorized by EF and kidney function from 1992 to 2000 in the CHS. EF, ejection fraction; eGFR, estimated glomerular filtration rate (mL/min per 1.73 m2). EF, ejection fraction.
Journal of Cardiac Failure  , 19-26DOI: ( /j.cardfail )
Copyright © 2008 Elsevier Inc. Terms and Conditions

4. Fig 3
Competing risks hazards (95% confidence intervals) for incident HF with an EF ≥ 50% or < 50% by serum cystatin C concentration in the CHS 1992–2000. Data are splines adjusted for age, sex, and race with 2.5% of the data removed from both ends. Vertical dotted lines delineate cystatin C quartiles (≤0.92, 0.92–1.05, 1.06–1.22, ≥1.23 mg/L). EF, ejection fraction.
Journal of Cardiac Failure  , 19-26DOI: ( /j.cardfail )
Copyright © 2008 Elsevier Inc. Terms and Conditions